Ajooni Biotech Limited
NSE: AJOONI · Other · sector
₹2.87NSE close 2026-10-26
Key numbers
Market cap₹49 cr
Price₹2.87
52w high / low₹6 / ₹3
P/E12.0xSector median 14.4x
P/B0.6xSector median 1.7x
Book value₹5.3
Dividend yield–Sector median 0.37%
ROE4.4%Sector median 13.8%
ROCE6.0%Sector median 19.6%
OPM3.4%Sector median 10.4%
Debt / equity0.19xSector median 0.29x
EV/EBITDA9.3xSector median 8.4x
Interest cover5.8x
Current ratio2.72x
Sales growth 3y+34.8%Sector median +7.7%
Profit growth 3y+56.6%Sector median +16.6%
PEG–
Last 12 months to Jun 2026, Standalone. "Sector median" = middle value of 688 companies in Other (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹0 cr vs borrowings ₹18 cr (FY26): borrowings are higher by ₹17 cr.
- Operating profit covered interest 5.8x in the last 12 months.
- Promoter holding rose by 3.64 percentage points in a year, to 30.53% (2026-09-30).
- Operating cash flow was below net profit in 4 of the last 5 years (FY26, FY25, FY24, FY23).
- Revenue was higher than a year earlier in 4 of the last 4 quarters.
- Other income was 52% of net profit in the last 12 months.
- Debtor days went from 59 (FY24) to 36 (FY26).
- No dividend in the last 5 financial years.
- Price ₹2.87 on 2026-10-26: -47.8% from the 52-week high, +7.1% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Weekly close · high ₹8.62 · low ₹2.87
RevenueNet profit
RevenueNet profit
Quarterly results
| ₹ cr | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 26 | 34 | 29 | 31 | 32 | 59 | 61 | 63 |
| EBITDA | 1 | 1 | 1 | 1 | 2 | 3 | 1 | 2 |
| OPM % | 3.0% | 2.7% | 3.5% | 2.3% | 4.7% | 5.2% | 1.6% | 2.6% |
| Other income | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 |
| Net profit | 1 | 1 | 2 | 1 | 1 | 2 | 1 | 0 |
| EPS (₹) | 0.04 | 0.04 | 0.09 | 0.02 | 0.08 | 0.10 | 0.05 | 0.01 |
| Revenue YoY | +23.4% | +72.6% | +107.1% | +103.0% | ||||
| Profit YoY | +50.0% | +126.0% | -38.3% | -44.9% |
Standalone figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 74 | 74 | 80 | 115 | 182 | 215 |
| EBITDA | 3 | 3 | 2 | 4 | 6 | 7 |
| Net profit | 1 | 1 | 2 | 3 | 4 | 4 |
| EPS (₹) | 0.21 | 1.94 | 0.25 | 0.20 | 0.25 | 0.24 |
| Revenue growth | +0.6% | +7.5% | +43.2% | +59.0% | +78.4% | |
| Profit growth | +6.7% | +92.9% | +56.0% | +28.2% | +7.9% | |
| Dividend / share (₹) | – | – | – | – | – |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | +34.8% | +29.0% | +78.4% |
| Net profit | +56.6% | +63.2% | +7.9% |
| EPS | -49.5% | +27.6% | – |
| Share price | – | -37.2% (2y) | -42.9% |
Balance sheet
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Shareholders' equity | – | 41,66,933 | 43 | 88 | 91 |
| Borrowings | – | 5,17,693 | 2 | 2 | 18 |
| Cash & equivalents | – | 30,934 | 0 | 7 | 0 |
| Total assets | – | 58,73,144 | 48 | 95 | 120 |
| Fixed assets | – | 6,28,911 | 10 | 11 | 26 |
| Capital work in progress | – | 26,185 | 1 | 0 | 0 |
| Investments | – | 3,73,722 | 2 | 3 | 2 |
| Receivables | – | 20,55,109 | 13 | 16 | 18 |
| Inventory | – | 6,99,396 | 15 | 24 | 39 |
| Payables | – | 10,11,114 | 2 | 4 | 9 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash from operations | 4 | -6 | -4 | -18 | -6 |
| Cash from investing | -2 | -16 | 8 | -17 | -16 |
| Cash from financing | -2 | 22 | -4 | 25 | 15 |
| Capex | 2 | 3 | 6 | 3 | 18 |
| Free cash flow | 2 | -8 | -10 | -21 | -24 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| ROE % | – | 0.0% | 5.1% | 3.8% | 4.7% |
| ROCE % | – | 0.0% | 7.9% | 5.2% | 5.9% |
| Debtor days | – | 1,00,70,332 | 59 | 52 | 36 |
| Inventory days | – | 38,83,010 | 80 | 90 | 97 |
| Payable days | – | 56,13,650 | 8 | 13 | 22 |
| Cash conversion cycle (days) | – | 83,39,692 | 131 | 129 | 111 |
| Working capital days | – | 95,36,556 | 134 | 182 | 94 |
Shareholding
| Holder | % (2026-09-30) |
|---|---|
| Promoters | 30.53% |
| Public (non-institutions) | 69.47% |
| Quarter | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Aug 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters % | 26.89% | 26.89% | 26.89% | 26.89% | 26.89% | 26.89% | 30.53% | 30.53% |
| Promoter group | % |
|---|---|
| Jasjot Singh | 15.98% |
| Healthy Biosciences Limited | 4.97% |
| Parmjeet Kaur | 4.30% |
| Upneet Kaur | 2.42% |
| Ashmeet Kaur | 1.75% |
| Ishneet Kaur | 1.11% |
| Prism Medico and Pharmacy Limited | 0.00% |
59,633 shareholders. Pledged: – of promoter shares.
Peers in Other
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| TSFINV | ₹8,585 cr | 17.6x | 1.4x | 8.4% | 3.6% | 20.5% | +121.7% | 2.30% |
| KRISHANA | ₹6,339 cr | 39.9x | 11.3x | 41.6% | 23.2% | 12.6% | +95.7% | 0.05% |
| MARINE | ₹5,431 cr | 84.2x | 11.0x | 14.3% | 18.0% | 10.8% | +25.6% | 0.07% |
| ZOTA | ₹4,139 cr | – | 6.0x | -22.5% | -12.4% | -0.5% | +56.7% | 0.07% |
| AIMTRON | ₹3,319 cr | 71.7x | 17.1x | 28.0% | 31.8% | 21.8% | – | – |
| ACCORD | ₹2,984 cr | – | 261.7x | 12.4% | 12.0% | 2.4% | – | – |
| MONOLITH | ₹2,646 cr | 64.6x | 24.3x | 36.0% | 48.7% | 24.4% | – | – |
| UTSSAV | ₹2,390 cr | 40.2x | 14.1x | 43.4% | 54.7% | 7.9% | – | – |
| BETA | ₹2,200 cr | 40.6x | 5.0x | 16.4% | 17.0% | 20.8% | – | – |
| AJOONI | ₹49 cr | 12.0x | 0.6x | 4.4% | 6.0% | 3.4% | +34.8% | – |
Dividends & corporate actions
| Ex-date | Action | Detail |
|---|---|---|
| 2024-09-10 | Other | Annual General Meeting |
| 2024-05-07 | Rights | Rights 1:1 @ Premium Rs 3/- |
| 2023-08-29 | Other | Annual General Meeting |
| 2022-11-25 | Rights | Rights 29:30 @ Premium Rs 4/- |
| 2022-10-07 | Split | Face Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 2/- Per Share |
| 2022-09-13 | Other | Annual General Meeting |
| 2021-09-17 | Other | Annual General Meeting |
Documents
- Annual report FY26
- Annual report FY25
- Annual report FY24
- Annual report FY22
- Annual report FY21
- Announcements NSE filings
- Latest results (data file) XBRL
Links go to the original files on the exchange website.
About the company
| Sector | |
| Industry | Other |
| Sub-industry | |
| Symbol | AJOONI |
| BSE code | – |
| ISIN | INE820Y01021 |
| Face value | ₹2.0 |
| Incorporated | – |
| Website | – |
| Plants (India / abroad) | – |
Data built 2026-10-23 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.